38
Participants
Start Date
October 31, 2008
Primary Completion Date
December 31, 2008
Study Completion Date
February 28, 2009
CAM-3001
A single patient shall be dosed with a dose of 0.01mg/kg of CAM-3001 followed no sooner than 24 hours later by a second patient at a dose of 0.03mg/kg.
CAM-3001
Dosed at 0.1mg/kg.
CAM-3001
Dosed at 0.3mg/kg
CAM-3001
Dosed at 1.0 mg/kg.
CAM-3001
Dosed at 3.0 mg/kg.
CAM-3001
Dosed at 10 mg/kg.
Placebo
Active: Placebo 5:1 for arms 2-6
Charite Research Organization GmbH, Berlin
Lead Sponsor
MedImmune Ltd
INDUSTRY